9,10-dimethyl-1,2-benzanthracene has been researched along with Cancer of Spleen in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doi, ST; Katsuki, M; Kimura, M | 1 |
| Chiang, H; Fu, YD; Shao, BJ; Shen, YH; Yu, M | 1 |
| Ben-Hur, H; Kossoy, G; Kossoy, N; Zusman, I | 1 |
3 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and Cancer of Spleen
| Article | Year |
|---|---|
Site-specific mutation of the human c-Ha-ras transgene induced by dimethylbenzanthracene causes tissue-specific tumors in mice.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Amino Acid Sequence; Animals; Base Sequence; Carcinoma, Squamous Cell; Codon; Genes, ras; Hemangiosarcoma; Humans; Lung Neoplasms; Methylnitrosourea; Mice; Mice, Transgenic; Molecular Sequence Data; Mutagenesis, Site-Directed; Oligonucleotide Probes; Point Mutation; Polymerase Chain Reaction; Promoter Regions, Genetic; Splenic Neoplasms; Stomach Neoplasms | 1994 |
The effects of 50 Hz magnetic field exposure on dimethylbenz(alpha)anthracene induced thymic lymphoma/leukemia in mice.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Electromagnetic Fields; Leukemia, Experimental; Leukemia, Myeloid; Liver Neoplasms; Lymphoma; Mice; Neoplasm Metastasis; Splenic Neoplasms; Thymus Neoplasms | 1997 |
Effects of the soluble low-molecular-mass proteins on spleen activity and cellular composition of infiltrates in rat mammary gland tumors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antigens, Neoplasm; Cancer Vaccines; CD8-Positive T-Lymphocytes; Female; Ki-67 Antigen; Lymphocytes, Tumor-Infiltrating; Mammary Neoplasms, Animal; Molecular Weight; Rats; Solubility; Spleen; Splenic Neoplasms | 2001 |